My prediction was a bit more conservative only because infected burns don't have the same scope and potential as sepsis or sinusitis. I think those results will really get her rocketing.
Having said that I was pondering the other day why they might have chosen burns as one of their original targets and I think it could be a stroke of genius. Having a drug be safe to ingest or take intravenous is a much more considerable challenge, but topical is much easier/safer. could it be they chose burns as a safe backstop for the company/drug/stock?
My prediction was a bit more conservative only because infected...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.010(3.33%) |
Mkt cap ! $83.62M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 29.5¢ | 29.0¢ | $33.79K | 116.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 135924 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 9974 | 2 |
View Market Depth
| Last trade - 11.57am 23/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |